ALLE
46
2
HAL
54
4
GOOG
59
2
GRMN
45
8
TXN
52
2
CMI
75
4
PAYX
41
5
IFF
59
2
BLK
63
5
FTI
64
-5
CL
62
4
KLAC
75
3
HON
68
-2
V
54
2
MS
76
2
WHR
48
-2
SJM
14
2
PCG
77
3
IR
63
5
CNP
52
3
ALLE
46
2
HAL
54
4
GOOG
59
2
GRMN
45
8
TXN
52
2
CMI
75
4
PAYX
41
5
IFF
59
2
BLK
63
5
FTI
64
-5
CL
62
4
KLAC
75
3
HON
68
-2
V
54
2
MS
76
2
WHR
48
-2
SJM
14
2
PCG
77
3
IR
63
5
CNP
52
3
Financhill
Back

Global X Genomics & Biotechnology ETF Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
56

GNOM
Global X Genomics & Biotechnology ETF

Last Price:
$47.55
Seasonality Move:
-14.17%
Sell
41

MNPR
Monopar Therapeutics, Inc.

Last Price:
$71.98
Seasonality Move:
25.93%
Buy
56
Global X Genomics & Biotechnology ETF (GNOM) is a Buy

Is Global X Genomics & Biotechnology ETF a Buy, Sell or Hold?

  • The current Global X Genomics & Biotechnology ETF [GNOM] share price is $47.98. The Score for GNOM is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • GNOM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $70.92. The Score for MNPR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GNOM Stock Price Chart

What is Global X Genomics & Biotechnology ETF's stock price today?

  • The Global X Genomics & Biotechnology ETF share price today is $47.98
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GNOM is experiencing buying pressure, which is a positive indicator for future bullish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $70.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

GNOM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.8 Buy
Relative Strength Index (14 RSI): 64.88 Buy
Chaikin Money Flow: 11340 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.15 - 47.41) Buy
Bollinger Bands (100): (37 - 45.02) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.54 Sell
Relative Strength Index (14 RSI): 41.3 Sell
Chaikin Money Flow: 7856 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (71.72 - 85.64) Sell
Bollinger Bands (100): (46.03 - 89.35) Buy

GNOM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.68 Buy
20-day SMA: 46.49 Buy
50-day SMA: 44.57 Buy
200-day SMA: 36.97 Buy
8-day EMA: 46.81 Buy
20-day EMA: 46.19 Buy
50-day EMA: 44.36 Buy
200-day EMA: 39.96 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 71.44 Sell
20-day SMA: 77.62 Sell
50-day SMA: 81.13 Sell
200-day SMA: 52.54 Buy
8-day EMA: 71.33 Sell
20-day EMA: 75.43 Sell
50-day EMA: 76.56 Sell
200-day EMA: 56.82 Buy

Global X Genomics & Biotechnology ETF Earnings Growth & GNOM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Global X Genomics & Biotechnology ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):